Optima Health (OPT) Q2 2027 TU earnings summary

Executive summary

• H1 FY27 revenue expected at ~£96m, ~60% above H1 FY26, driven by PAM Healthcare and continued growth in core operations; trading in line with Board expectations.

• Integration is progressing to plan, synergies are being realised, and the outlook remains on track for FY27 results in line with market expectations.

Financial highlights

• H1 FY27 revenue expected at ~£96m vs £59.5m in H1 FY26, reflecting PAM Healthcare and growth in occupational health and wellbeing operations.

• Annualised new business wins were £10.6m in H1 FY27 vs £1.9m in H1 FY26.

Outlook and guidance

• FY27 results remain expected to be in line with current market expectations.

• Entering H2 with a strong public- and private-sector pipeline and increasing operational momentum.

• Interim results for the six months ended 30 September 2026 expected by December 2026.